OGEN vs TER · rev $37.7K vs P/E 76, rev $2.82B
Oragenics Inc (OGEN) versus Teradyne Inc (TER) — a side-by-side from cached financials, not a winner call.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
Teradyne Inc (TER) is a semiconductor equipment & materials company listed on NASDAQ.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
Latest reported TER revenue for 2024-12-31 was $2.82B. Net income was $542.4M. Revenue was up 5.4% from 2023-12-31 to 2024-12-31. TER currently screens at market cap $63.96B and trailing P/E 75.7.
OGEN currently screens at market cap $2.7M. TER currently screens at market cap $63.96B and trailing P/E 75.7.
Not investment advice. Open the OGEN and TER stock pages for the full models.
Not investment advice.